https://doctransparency.com/doctor/fl/naples/jeffrey-alper-1689663296
Medicare Enrolled

Dr. Jeffrey Alper, MD P A

Rheumatology · Naples, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
6605 HILLWAY CIR STE 101, Naples, FL 34112
2392626550
In practice since 2005 (20 years)
NPI: 1689663296 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Alper from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alper? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Alper

Dr. Jeffrey Alper is a rheumatology in Naples, FL, with 20 years in practice. Based on federal Medicare data, Dr. Alper performed 355,905 Medicare services across 1,549 unique beneficiaries.

Between the years covered by Open Payments, Dr. Alper received a total of $25,091 from 47 pharmaceutical and/or device companies across 946 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Alper is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 1% volume in FL$ $25,091 industry payments

Medicare Practice Summary

Medicare Utilization ↗
355,905
Medicare services
Top 1% in FL for rheumatology
1,549
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~17,795 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)161,000$4$11
Tocilizumab injection (Actemra)78,360$5$11
Golimumab infusion (Simponi Aria)35,340$11$27
Abatacept infusion (Orencia)33,700$34$83
Romosozumab injection (Evenity) for osteoporosis29,610$8$22
Denosumab injection (Prolia/Xgeva)11,100$18$43
Infliximab infusion (Remicade)3,420$26$69
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle1,206$59$140
Administration of chemotherapy into vein, 1 hour or less930$99$361
Office visit, established patient (30-39 min)666$99$281
Office visit, established patient (20-29 min)213$65$192
Administration of chemotherapy into vein, each additional hour120$22$115
New patient office visit (45-59 min)99$122$434
Injection, zoledronic acid, 1 mg95$7$16
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less19$46$270
New patient office visit, complex (60-74 min)14$176$547
New patient office visit (30-44 min)13$70$287
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
20.4% high complexity
79.4% medium
0.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$25,091
Total received (2018-2024)
Avg $3,584/year across 7 years
Top 19% in FL for rheumatology
47
Companies
946
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,132 (76.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,449 (21.7%)
Scientific / Research
Research funding and grants
$445 (1.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$65 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,014
2023
$3,748
2022
$3,527
2021
$2,476
2020
$2,040
2019
$2,985
2018
$7,302

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Flexion Therapeutics, Inc.
$5,485
Amgen Inc.
$4,534
UCB, Inc.
$1,830
Novartis Pharmaceuticals Corporation
$1,528
Janssen Biotech, Inc.
$1,363
Lilly USA, LLC
$910
AstraZeneca Pharmaceuticals LP
$882
GlaxoSmithKline, LLC.
$770
ABBVIE INC.
$759
Horizon Therapeutics plc
$756
Mallinckrodt Hospital Products Inc.
$725
AbbVie, Inc.
$717
PFIZER INC.
$624
AbbVie Inc.
$600
E.R. Squibb & Sons, L.L.C.
$561
Mallinckrodt Enterprises LLC
$388
Genentech USA, Inc.
$344
Radius Health, Inc.
$267
GENZYME CORPORATION
$262
Boehringer Ingelheim Pharmaceuticals, Inc.
$260
Celgene Corporation
$211
Fresenius Kabi USA, LLC
$118
Gilead Sciences, Inc.
$116
NOVARTIS PHARMACEUTICALS CORPORATION
$115
Aurinia Pharma U.S., Inc.
$97
Mallinckrodt LLC
$97
Horizon Pharma plc
$71
SANOFI-AVENTIS U.S. LLC
$65
Genentech, Inc.
$57
NeuroMetrix Inc
$54
Alvogen Inc
$52
Almatica Pharma LLC
$49
Sandoz Inc.
$47
Fidia Pharma USA Inc.
$46
Sobi, Inc
$45
Ironwood Pharmaceuticals, Inc
$38
West-Ward Pharmaceuticals
$33
Pacira Therapeutics, Inc.
$31
FIDIA PHARMA USA INC.
$30
SOBI, INC
$21
Takeda Pharmaceuticals U.S.A., Inc.
$20
Mylan Institutional Inc.
$20
DePuy Synthes Sales Inc.
$20
Cumberland Pharmaceuticals, Inc.
$19
Organon Llc
$18
Alexion Pharmaceuticals, Inc.
$18
Exeltis, USA Inc.
$17
Top 3 companies account for 47.2% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · Cimzia · DUZALLO · EVENITY · EVUSHELD · Enbrel · FASENRA · FORTEO · HUMIRA · HYM/HYN · HYMOVIS · HYRIMOZ · Hulio · Humira · Hymovis · IDACIO · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REDITREX · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · Uloric · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (76%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $7 per 100 Medicare services performed
Looking for a rheumatology in Naples?
Compare rheumatologys in the Naples area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
9
Per 100K population
2.3
County median income
$86,173
Nearest hospital
NAPLES COMMUNITY HOSPITAL
3.9 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Alper is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (low-engagement, top 19%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Alper experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Alper performed 161,000 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alper receive payments from pharmaceutical companies?
Yes. Dr. Alper received a total of $25,091 from 47 companies across 946 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alper's costs compare to other rheumatologys in Naples?
Dr. Alper's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alper) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →